loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Pancrelipase

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Pancrelipase

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 242Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Viokase`s Biologic Viokace (pancrelipase) Receives Approval in the U.S.
    Viokase`s Biologic Viokace (pancrelipase) Receives Approval in the U.S.

    28 Feb 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022542

    FDA
    28 Feb 2024
    Share Share
    Vivus' Biologic Pancreaze (pancrelipase) Receives Approval in the U.S.
    Vivus' Biologic Pancreaze (pancrelipase) Receives Approval in the U.S.

    28 Feb 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022523

    FDA
    28 Feb 2024
    Share Share
    Digestive care`s Biologic Pertzye (pancrelipase) Receives Approval in the U.S.
    Digestive care`s Biologic Pertzye (pancrelipase) Receives Approval in the U.S.

    28 Feb 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022175

    FDA
    28 Feb 2024
    Share Share
    Eurand's Biologic Zenpep (pancrelipase) Receives Approval in the U.S.
    Eurand's Biologic Zenpep (pancrelipase) Receives Approval in the U.S.

    27 Oct 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022210

    FDA
    27 Oct 2023
    Share Share
    AbbVie to Present Data from Extensive Portfolio at Annual Scientific Meeting
    AbbVie to Present Data from Extensive Portfolio at Annual Scientific Meeting

    24 Oct 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/abbvie-to-present-data-from-extensive-portfolio-at-american-college-of-gastroenterology-annual-scientific-meeting-301656494.html

    PRNEWSWIRE
    24 Oct 2022
    Share Share
    Digestive's Biologic Pertzye (Pancrelipase) Receives Approval in the U.S.
    Digestive's Biologic Pertzye (Pancrelipase) Receives Approval in the U.S.

    28 Sep 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022175

    FDA
    28 Sep 2022
    Share Share